Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is causing an ongoing
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …

The mechanisms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) egress,
similar to those of other coronaviruses, remain poorly understood. The virus buds in …

Background The outbreak of a new virus known as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has now become the main health concern all over the world …

Corona virus disease 2019 (COVID-19) is a global public health crisis. The high infectivity of
the disease even from non-symptomatic infected patients, together with the lack of a …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces
inflammatory response, cytokine storm, venous thromboembolism, coagulopathy, and …

Given that conventional therapies are ineffective for COVID-19, obtained exosomes from
stem cells have been proposed as a sustainable and effective treatment. Exosomes are …

Acute respiratory distress syndrome (ARDS) is the main cause for the COVID-19 infection-
related morbidity and mortality. Recent clinical evidences suggest increased level of …

Severe COVID‐19 infection results in bilateral interstitial pneumonia, often leading to acute
respiratory distress syndrome (ARDS) and pulmonary fibrosis in survivors. Most patients with …

Coronavirus disease 2019 (COVID-19) is a pandemic viral disease originated in Wuhan,
China, in December 2019, caused by the severe acute respiratory syndrome coronavirus 2 …

Background Extracellular vesicles (EVs) are mediators of cell-to-cell communication in
inflammatory lung diseases. They function as carriers for miRNAs which regulate mRNA …